Trending...
- MSDirect.com.au Unveils 2026 Furniture Collection: Affordable Luxury for Every Australian Home
- Genuine Hospitality, LLC Selected to Operate Hilton Garden Inn Birmingham SE / Liberty Park
- Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
FAYETTEVILLE, Ark. & HARRISBURG, Pa. - AussieJournal -- After securing two new distribution partnerships in the final months of 2021, Lineus Medical continues to expand its distribution network with the addition of Capitol Medical, a specialty medical distributor based out of Harrisburg, PA. The Capitol Medical sales team services the Mid-Atlantic region, covering West Virginia, Pennsylvania, New Jersey, New York, and Delaware. The group employs 5 salespeople covering this geographic territory.
"With the Mid-Atlantic region being so densely populated, we knew it was critical to find a top tier group to represent us in this territory," Vance Clement, CEO of Lineus Medical stated. "With Capitol Medical's experienced team and proven track record of sales success, we expect this to be fruitful partnership for both parties."
More on Aussie Journal
"Capitol Medical is thrilled to partner with Lineus Medical and we believe SafeBreak Vascular is going to be a game changer for patients and nurses," said John Bixler, Sales Manager at Capitol Medical. "Representing innovative products that improve patient care is core to our mission, so we're excited to add SafeBreak Vascular to our product portfolio."
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world. The device is designed to separate when damaging force is placed on an IV line, reducing vein irritation and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient.
More on Aussie Journal
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually2.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
MKG-0125 Rev 00
"With the Mid-Atlantic region being so densely populated, we knew it was critical to find a top tier group to represent us in this territory," Vance Clement, CEO of Lineus Medical stated. "With Capitol Medical's experienced team and proven track record of sales success, we expect this to be fruitful partnership for both parties."
More on Aussie Journal
- The 22% Tax Reality: Finland's New Gambling Law Creates a "Fiscal Trap" for Grey Market Casino Players
- ServiceTasker Launches Auto-Quoting Feature to Deliver Instant, Exclusive Leads for Local Businesses
- Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
- Layna Activewear Launches Limited-Time "2 for $100" Leggings Offer with Free AU Shipping
- Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion
"Capitol Medical is thrilled to partner with Lineus Medical and we believe SafeBreak Vascular is going to be a game changer for patients and nurses," said John Bixler, Sales Manager at Capitol Medical. "Representing innovative products that improve patient care is core to our mission, so we're excited to add SafeBreak Vascular to our product portfolio."
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer lock in the world. The device is designed to separate when damaging force is placed on an IV line, reducing vein irritation and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient.
More on Aussie Journal
- Golden Paper Launches a New Chapter in Its Americas Strategy- EXPOPRINT Latin America 2026 in Brazil
- UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
- TheOneLofi2: New Home for Chill Lo-Fi Hip Hop Beats Launches on YouTube
- eJoule Inc Participates in Silicon Dragon CES 2026
- HBZBZL Unveils "Intelligent Ecosystem" Strategy: Integrating AI Analytics with Web3 Incubation
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Peripheral IVs fail 46% of the time before their intended use is complete according to the clinical literature and cost the US healthcare system over $5B annually2.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a unique, patented, break-away technology that can be adapted for use with a variety of medical tubing. Dislodgement of feeding tubes, IV lines, urinary catheters and any other type of medical line could be prevented with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015;38(3): 189-203
MKG-0125 Rev 00
Source: Lineus Medical
Filed Under: Health
0 Comments
Latest on Aussie Journal
- Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
- Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
- What is it Total and Permanent Disability (TPD) Insurance?
- Humidity Control in Remote Sites – Without a Water Supply
- UK Financial Ltd Launches U.S. Operations Following Delaware Approval
- Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
- Why Engaging a Specialist Business Valuer Matters
- Nutrition Tips for Toddlers: Healthy Habits Start Early
- Beycome Closes $2.5M Seed Round Led by InsurTech Fund
- Tru by Hilton Columbia South Opens to Guests
- Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
- "BigPirate" Sets Sail: A New Narrative-Driven Social Casino Adventure
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- Microgaming Unveils Red Papaya: A New Studio Delivering Cutting-Edge, Feature-Rich Slots
- Citywide Service Solutions divestment of their NSW, Queensland and ACT (NAQ) Horticulture and Open Space Division
- 5-Star Duncan Injury Group Expands Personal Injury Representation to Arizona
- The End of "Influencer" Gambling: Bonusetu Analyzes Finland's Strict New Casino Marketing Laws
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue



